Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Subjects clinically indicated for nuclear stress test and who satisfy all the inclusion and exclusion criteria are eligible for participation.~Inclusion criteria:~Age 22 years or older Willing and able to give informed consent Clinical indication for nuclear stress test evaluation Chest pain syndrome~Two or more coronary artery disease risk factors as defined by:~1. Dyslipidemia: low-density lipoprotein (LDL) \>130 mm/dL or high-density lipoprotein (HDL) \<35 mm/dL or on treatment for dyslipidemia~2. Hypertension: blood pressure \>140 millimeter of mercury (mmHg) systolic, \>90 mmHg diastolic or on blood pressure altering treatment~3. Obesity: body mass index (BMI)\>28~4. Current cigarette smoking~5. Diabetes: Type 1 or 2~6. Family history: coronary disease in a first or second degree relative~Exclusion criteria:~Body Mass Index (BMI)\<18.5 or BMI \>40~Known coronary disease as defined as:~Prior bypass surgery or coronary stenting Q-wave infarction on a past electrocardiogram (EKG) (\>0.01 sec Q-wave duration in two adjacent leads)~Presence of pacemaker/defibrillator Presence of artificial valve Presence of obvious cyanotic or pre-diagnosed congenital heart defect and coarctation of the aorta Presence murmurs including valve lesions, ventricular septal defects, and arteriovenous (AV) fistulae.~Presence of moderate or severe valve disease as defined by \>1/6 heart murmur on physical diagnosis Left Ventricular Assist Device (LVAD) Presence of scars on the site thorax areas Participation in trial within 30 days prior to collecting CADence data except participation in registry studies Asthma with wheezing Inability to lie flat in the supine position Acute coronary syndrome with elevated cardiac biomarkers (troponin (TP)\>3x upper limit of normal (ULN) or creatine kinase MB (CKMB) \>3x ULN) Heart Transplant Current cocaine use (within the past 24 hours, as reported by subject) Chronic Obstructive Pulmonary Disease (COPD) Contraindication to computed tomography (CT) angiography~* Renal failure with glomerular filtration rate (GFR)\<50 (angio risk)~* Iodinated contrast allergy~* Elevated heart rate which cannot be controlled sufficiently to achieve a good computed tomography angiogram~* Body weight \>350lbs.~* Sinus rhythm rate greater than 100 beats per minute at screening.~* Atrial fibrillation with average heart rate of greater than 70 beats per minute on resting screening electrocardiogram (ECG).

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CADence plus Standard Angiogram (Type: None): All patients who were indicated for angiogram due to results of SPECT nuclear stress test
- CADence plus CT Angiogram (Type: None): All patients who were not indicated for angiogram due to results of SPECT nuclear stress test underwent CT angiogram

Based on this trial design, predict the completion outcome and termination type (if applicable).